BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2017
View Archived Issues
Shionogi profiles key developments of second quarter of fiscal 2017
Read More
NeoMatrix Therapeutics to begin clinical testing of NMT-cP12
Read More
Enrollment begins in phase I study of Samumed's SM-04755
Read More
Integrated BioTherapeutics receives support from CARB-X to develop IBT-V02
Read More
VS-505 effective and well tolerated hyperphosphatemia treatment for hemodialysis patients
Read More
Mallinckrodt to acquire Ocera Therapeutics
Read More
Seattle Genetics submits sBLA in U.S. for Adcetris
Read More
First-in-human study reported for next-generation PET tau tracer 18F-PI-2620
Read More
FDA awards orphan drug status to RT-001 for PLA2G6-associated neurodegeneration
Read More
Hungarian Academy of Sciences identifies novel P-glycoprotein inhibitors
Read More
Janssen describes recombinant pre-fusion respiratory syncytial virus fusion proteins
Read More
Trevena submits NDA in U.S. for Olinvo
Read More
Yissum Research Development creates new methylmalonyl coenzyme A mutase fusion constructs
Read More
Mitsubishi Tanabe Pharma acquires Stelic Institute
Read More
Novel NLRP3 inflammasome inhibitors presented by IFM Therapeutics
Read More
National Institute of Biomedical Innovation patents exosome-targeted DNA vaccines
Read More
FF-1027T demonstrates tumor growth inhibition in AML xenograft model
Read More
Kamada reports topline results from study of AAT in type 1 diabetes
Read More
O-304 reduces fasting plasma glucose in phase IIa study in type 2 diabetes
Read More
Boehringer Ingelheim announces a new research collaboration and advances an existing one
Read More
IntelGenx and RedHill Biopharma resubmit NDA for Rizaport
Read More
Concentric Analgesics begins phase Ib study of capsaicin prodrug
Read More
Vedantra and Neon Therapeutics extend cancer immunotherapy research alliance
Read More
Progenics Pharmaceuticals completes rolling NDA for Azedra
Read More
GSK-3389404 well tolerated in first-in-human study
Read More
STRATOS 2 and TROPOS trials of tralokinumab in severe asthma do not meet primary endpoints
Read More
Inhibrx wins award from CARB-X for development of INBRX-111 to treat Pseudomonas infections
Read More
Oryzon Genomics cleared to conduct phase IIa SATEEN study of ORY-2001
Read More
Vedanta sublicenses IP from JSR for microbiome-derived cancer immunotherapies
Read More
Preliminary phase I results for bispecific FAP-DR5 antibody RG-7386 in solid tumor patients
Read More
Novo Nordisk offers overview of third quarter 2017
Read More
Nicox announces FDA approval of Vyzulta, recaps pipeline progress
Read More